Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019
Cash Flows From Operating Activities
Net (loss) Income	$ (3,067,570)	$ 1,558,060
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,004,539	1,114,678
Provision for obsolete inventory	41,433	307,836
Provision for loss on accounts and notes receivable	1,468,815	134,783
Asset impairment and store closure losses	544,060
Loss (gain) on sale or disposal of property and equipment	(199,774)	8,307
Forgiveness of indebtedness	(107,700)
Expense recorded for stock compensation	399,636	503,210
Deferred income taxes	(990,129)	57,793
Changes in operating assets and liabilities:
Accounts receivable	435,536	(982,237)
Refundable income taxes	(3,252)	(132,040)
Inventories	(1,262,189)	294,361
Other current assets	101,436	(45,820)
Accounts payable	(376,375)	1,206,354
Accrued liabilities	12,613	182,625
Contract liabilities	(13,688)	(175,918)
Net cash (used in) provided by operating activities	(2,012,609)	4,031,992
Cash Flows from Investing Activities
Proceeds received on notes receivable	69,583	109,342
Purchase of intangible assets	(99,048)	763
Proceeds from insurance recovery	304,962
Purchases of property and equipment	(77,059)	(864,370)
Decrease in other assets		313
Net cash used in investing activities	198,438	(753,952)
Cash Flows from Financing Activities
Payments on long-term debt		(1,048,912)
Proceeds from long-term debt	1,537,200
Proceeds from the line of credit	3,448,165
Dividends paid	(722,344)	(2,150,477)
Net cash provided by (used in) financing activities	4,263,021	(3,199,389)
Net Increase (Decrease) in Cash and Cash Equivalents	2,448,850	78,651
Cash and Cash Equivalents, Beginning of Period	4,822,071	5,384,027
Cash and Cash Equivalents, End of Period	$ 7,270,921	$ 5,462,678